Resources

References

Peer-reviewed primary literature, diagnostic criteria and guidelines cited throughout the chapter. Every citation was verified against PubMed (NCBI E-utilities) and carries a PMID and DOI; click either to open the source.

  1. Committee on Hearing and Equilibrium, American Academy of Otolaryngology–Head and Neck Surgery
    Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease.
    Otolaryngology–Head and Neck Surgery. 1995;113(3):181–185.doi:10.1016/S0194-5998(95)70102-8PMID: 7675476The earlier guideline; source of the four-stage audiometric staging still in use.
  2. Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M
    Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of the BEMED trial.
    BMJ. 2016;352:h6816.doi:10.1136/bmj.h6816PMID: 26797774Randomised trial: betahistine no better than placebo on attack frequency.
  3. Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R, Bush ML, Bykowski J, Colandrea M, Derebery J, Kelly EA, Kerber KA, Koopman CF, Kuch AA, Marcolini E, McKinnon BJ, Ruckenstein MJ, Valenzuela CV, Vosooney A, Walsh SA, Nnacheta LC, Dhepyasuwan N, Buchanan EM
    Clinical practice guideline: Ménière's disease.
    Otolaryngology–Head and Neck Surgery. 2020;162(2_suppl):S1–S55.doi:10.1177/0194599820909438PMID: 32267799
  4. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A
    Diagnostic criteria for Ménière's disease.
    Journal of Vestibular Research. 2015;25(1):1–7.doi:10.3233/VES-150549PMID: 25882471The Bárány Society / AAO-HNS / EAONO / JSER / KBS international consensus criteria.
  5. Merchant SN, Adams JC, Nadol JB Jr
    Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?.
    Otology & Neurotology. 2005;26(1):74–81.doi:10.1097/00129492-200501000-00013PMID: 15699723Temporal-bone evidence that hydrops is a marker of, not necessarily the direct cause of, symptoms.
  6. Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH
    Meniere's disease.
    Nature Reviews Disease Primers. 2016;2:16028.doi:10.1038/nrdp.2016.28PMID: 27170253
  7. Patel M, Agarwal K, Arshad Q, Hariri M, Rea P, Seemungal BM, Golding JF, Harcourt JP, Bronstein AM
    Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    The Lancet. 2016;388(10061):2753–2762.doi:10.1016/S0140-6736(16)31461-1PMID: 27865535Intratympanic methylprednisolone was non-inferior to gentamicin — a gland-sparing option.
  8. Pullens B, van Benthem PP
    Intratympanic gentamicin for Ménière's disease or syndrome.
    Cochrane Database of Systematic Reviews. 2011;(3):CD008234.doi:10.1002/14651858.CD008234.pub2PMID: 21412917
  9. Sajjadi H, Paparella MM
    Meniere's disease.
    The Lancet. 2008;372(9636):406–414.doi:10.1016/S0140-6736(08)61161-7PMID: 18675691